Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer

@article{Allin2011ElevatedCP,
  title={Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer},
  author={Kristine H{\o}jgaard Allin and B{\o}rge Gr{\o}nne Nordestgaard},
  journal={Critical Reviews in Clinical Laboratory Sciences},
  year={2011},
  volume={48},
  pages={155 - 170}
}
The aim of this review is to summarize present evidence of an association between circulating levels of C-reactive protein (CRP) and cancer risk, and to evaluate whether elevated circulating CRP levels cause cancer. Additionally, the review provides background information on the acute-phase response, chronic inflammation, the molecular biology, function and measurement of CRP, circulating levels of CRP in health and disease, the principle of Mendelian randomization, the association between… Expand
View on Taylor & Francis
ncbi.nlm.nih.gov
360 Citations
Highly Influential Citations
12
Background Citations
117
Methods Citations
4
Results Citations
8

360 Citations

Citation Type

Citation Type

The role of C‐reactive protein in prostate cancer
TLDR
The association between serum CRP concentrations and relapse-free survival is examined in prostate cancer patients who received radiation therapy for localized disease, either in addition to radical prostatectomy or as definitive treatment. Expand
Therapeutic Lowering of C-Reactive Protein
TLDR
Evidence is generated using animal models of arthritis, neointimal hyperplasia, and acute kidney injury that baseline CRP exerts important biological effects and the possibility that therapeutic lowering of baselineCRP might be a useful way to treat certain diseases, including cancer is discussed. Expand
Serum C-reactive protein and overall survival of patients with osteosarcoma
TLDR
Patients with high serum CRP levels have an important prognostic significance in patients with osteosarcoma, and high CRP level is associated with worse overall survival. Expand
Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study
TLDR
The study corroborates a causative role of chronic low-grade inflammation in colorectal carcinogenesis and examines the associations of a CRP genetic risk score created from single-nucleotide polymorphisms with coloreCTal cancer risk, as well as examine plasma CRP and CRP-GRS in relation to common cancers in the ARIC cohort. Expand
Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancer.
TLDR
CRP is a sensitive and easily detectable serum marker that can be useful in patients with CRC, allowing their better clinical stratification. Expand
C-reactive protein and the biology of disease
TLDR
The present torrent of studies in a large number of diseases and associated conditions has highly elucidated the role of CRP as a therapeutic and research reagent and the future prospect of this review lies in the applicability of CRp as a molecule in understanding and monitoring of the biology of disease. Expand
C-reactive protein as a diagnostic and prognostic factor of endometrial cancer.
TLDR
CRP-to-albumin ratio as well as Glasgow Prognostic Score (GPS) have greater prognostic value that CRP alone, and CRP is possibly a mediator of carcinogenesis and cancer progression through activation of inter alia FcgRs/MAPK/ERK, FcGRs/IL-6/AKT/STAT3 and Fc gRs/NF-κB/NLRP3 pathways. Expand
A prospective study of plasma inflammatory markers and risk of colorectal cancer in men
TLDR
Plasma inflammatory markers are not generally associated with risk of colorectal cancer among men, however, the possibility that plasma IL-6 is associated with increased risk of CRC among lean men requires further investigation. Expand
Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings.
TLDR
Clear dose-effect relationships between elevated CRP levels and prognose indicate that CRP could be useful in predicting prognoses in patients with advanced cancer. Expand
C reactive protein level as a marker for dyslipidaemia, diabetes and metabolic syndrome: results from the Korea National Health and Nutrition Examination Survey
Objective Plasma C reactive protein (CRP) is a marker of inflammation, and increased plasma CRP is reported in many diseases, including cardiovascular disease, diabetes, metabolic syndrome, arthritis… Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 140 REFERENCES
C-reactive protein and the risk of cancer: a mendelian randomization study.
TLDR
It is suggested that elevated CRP levels do not cause cancer, as the estimated causal odds ratio for cancer associated with a genetically induced doubling in CRP level was 0.94, lower than expected. Expand
Plasma C-Reactive Protein and Risk of Cancer: A Prospective Study from Greece
TLDR
Although based on small number of cases, the association between elevated plasma CRP level and risk was stronger for cancers of the liver, lung, skin, kidney, and bladder, as well as for lymphoma and leukemia than for other neoplasms. Expand
C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
  • C. Siemes, L. Visser, +6 authors B. Stricker
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
TLDR
Baseline CRP levels seem to be a biomarker of chronic inflammation preceding lung cancer, even after subtracting a 5-year latent period, and both chronic inflammation and impaired defense mechanisms resulting in chronic inflammation might explain these results. Expand
C-reactive protein and risk of lung cancer.
TLDR
Elevated CRP levels are associated with subsequently increased lung cancer risk, suggesting an etiologic role for chronic pulmonary inflammation in lung carcinogenesis. Expand
A systematic review of the association between circulating concentrations of C reactive protein and cancer
TLDR
The objective of this study was to review and summarise the published evidence for an association between circulating concentrations of C reactive protein (CRP) and cancer through a systematic review, and identified 90 discrete studies that provided no strong evidence for a causal role of CRP in cancer. Expand
C-reactive protein and risk of breast cancer.
Chronic inflammation is hypothesized to be associated with breast cancer development. However, data evaluating the association between C-reactive protein (CRP), a marker of systemic inflammation, and… Expand
C-reactive protein and the risk of incident colorectal cancer.
TLDR
Plasma CRP concentrations are elevated among persons who subsequently develop colon cancer and support the hypothesis that inflammation is a risk factor for the development of colon cancer in average-risk individuals. Expand
C-reactive protein and cardiovascular disease: new insights from an old molecule.
TLDR
The presence of CRP within most atherosclerotic plaques and all acute myocardial infarction lesions, coupled with binding ofCRP to lipoproteins and its capacity for pro-inflammatory complement activation, suggests that CRP may contribute to the pathogenesis and complications of cardiovascular disease. Expand
Association of Elevated C-reactive Protein Levels With an Impaired Prognosis in Patients With Surgically Treated Endometrial Cancer
TLDR
The results suggest that elevated serum CRP levels are associated with a less favorable prognosis in patients with surgically treated endometrial cancer. Expand
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
TLDR
Elevated levels of CRP and IL-6 predict the development of type 2 DM, and data support a possible role for inflammation in diabetogenesis. Expand
...
1
2
3
4
5
...